Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
• Top New Articles on HCV
• All HCV Articles by Topic ( A to Z )
• HCV Basics
• HIV-HCV Coinfection
• FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
• Treatment Guidelines for HCV
• Experimental Treatments for HCV
• Recent Research Conference Reports
• Tests for HCV
• Liver-related Complications
• Drug-related Adverse Events
• Doctor Is In 'Q and A' for HCV
• Library of CME Programs
• E-mail Update - Sign Up
• About Us - Contact Us
_______________
HCV Core Antigen
Use of
HCV Core Antigen Assays
in the Management of Hepatitis C
- 2/04/05
Budget Impact Analysis of 2 Different Methods of Evaluating Early Viral Response to Peginterferon Alfa-2b (Peg-Intron) Plus Ribavirin Therapy in Genotype 1 Patients
- 12/03/04
Comparison of HCV RNA and HCV
Core Antigen
Kinetics Among HIV-HCV Co-Infected Patients in the RIBAVIC Trial
11/24/04
Clinical Value of Total
HCV Core Antigen
Detection and Quantification
05/26/04
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNOLOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US
